secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001493152-24-001713
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa CEO presents at Biotech Showcase 2024; no financial updates provided
-----------------------------------------------------------------------------

- CEO George Ng presentation on Jan 8, 2024 at 1:00 PM PT in San Francisco.
- Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients'.
- Presentation uploaded to investor portal and available on company website.
- No specific financial or pipeline results disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224001713/0001493152-24-001713-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315224001713/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001713

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer